Recruiting Cystic Fibrosis Studies in Chicago
Evaluation of VX-121/Tezacaftor/Deutivacaftor in Cystic Fibrosis (CF) Participants 1 Through 11 Years of Age
The purpose of this study is to evaluate the pharmacokinetics, safety, tolerability and efficacy of VX-121/tezacaftor/deutivacaftor (VX-121/TEZ/D-IVA) in CF participants with at least 1 triple combina...
4D-710 in Adult Patients With Cystic Fibrosis
This is a Phase 1/2 multicenter, open-label, single dose trial of 4D-710 investigational gene therapy in adults with cystic fibrosis....
About Cystic Fibrosis Clinical Trials in Chicago
Cystic fibrosis is a genetic disorder that causes thick, sticky mucus to build up in the lungs, digestive tract, and other organs. It is caused by mutations in the CFTR gene. CFTR modulator therapies have dramatically improved outcomes, along with airway clearance techniques and nutritional support.
There are currently 2 cystic fibrosis clinical trials recruiting participants in Chicago, IL. These studies are seeking a combined 250 participants. Research is being sponsored by Vertex Pharmaceuticals Incorporated, 4D Molecular Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.
Cystic Fibrosis Clinical Trials in Chicago — FAQ
Are there cystic fibrosis clinical trials in Chicago?
Yes, there are 2 cystic fibrosis clinical trials currently recruiting in Chicago, IL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Chicago?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chicago research site will contact you about next steps.
Are clinical trials in Chicago free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chicago studies also compensate for your time and travel.
What cystic fibrosis treatments are being tested?
The 2 active trials in Chicago are testing new therapies including novel drugs, biologics, and treatment approaches for cystic fibrosis.
Data updated March 2, 2026 from ClinicalTrials.gov